Is Krystal Biotech, Inc. overvalued?

Krystal Biotech, Inc. (KRYS) — key valuation metrics and fundamentals.

No verdict

Price

$334.16

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$9.85B

Dividend yield

0.0%

Return on equity

19.3%

Sector

Healthcare

Fair value compares KRYS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks